IM Cannabis Eyes Defense Pivot with Stake in Polish Cyber-Drone Firm…

Event summary

IM Cannabis (NASDAQ: IMCC) signs non-binding LOI to acquire 51% of Blackaxe, a Polish defense-tech firm specializing in drone interception and satellite intelligence.
Blackaxe's tech includes counter-UAS solutions and AI-driven satellite analytics based on Israeli defense technologies.
Transaction follows IMC’s earlier signal to diversify beyond medical cannabis into technology sectors.
Deal contingent on due diligence, definitive agreements, and regulatory approvals—no guarantee of completion.

The big picture

IMC’s proposed acquisition reflects broader trends in defense spending, where satellite intelligence and counter-drone tech are critical amid rising geopolitical tensions. The move signals a bet on diversifying into higher-growth sectors, though the company’s ability to execute remains unproven.

What we're watching

Execution Risk: Whether IMC can navigate regulatory hurdles and due diligence to close the deal.
Market Timing: The pace at which defense-tech demand grows amid ongoing conflicts in Eastern Europe and the Middle East.
Strategic Fit: How IMC integrates a high-tech defense subsidiary with its existing medical cannabis operations.